IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, cilt.22, sa.4, ss.407-411, 2019 (SCI-Expanded)
Objective(s): The current study was designed to investigate the therapeutic and protective effects of montelukast (ML) against doxorubicin (DOX)-induced acute kidney damage in rats.